121 related articles for article (PubMed ID: 25939126)
1. Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial.
Er F; Erdmann E; Nia AM; Dahlem KM; Biesenbach E; Herrfurth T; Taghiyev Z; Le MT; Hellmich M; Kuhr K; Caglayan E; Gassanov N
Int J Cardiol; 2015; 190():351-2. PubMed ID: 25939126
[No Abstract] [Full Text] [Related]
2. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
Er F; Dahlem KM; Nia AM; Erdmann E; Waltenberger J; Hellmich M; Kuhr K; Le MT; Herrfurth T; Taghiyev Z; Biesenbach E; Yüksel D; Eran-Ergöknil A; Vanezi M; Caglayan E; Gassanov N
JACC Cardiovasc Interv; 2016 Feb; 9(3):231-240. PubMed ID: 26847114
[TBL] [Abstract][Full Text] [Related]
3. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
[TBL] [Abstract][Full Text] [Related]
4. Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study.
Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; D'Egidio A; Cecchini V; Landoni G; Pietropaoli P; Westphal M; Venditti M; Mebazaa A; Singer M
Crit Care Med; 2013 Sep; 41(9):2162-8. PubMed ID: 23873274
[TBL] [Abstract][Full Text] [Related]
5. Esmolol activates endogenous neurokinin activity inhibiting infarction-induced arrhythmias in rats: novel mechanisms of anti-arrhythmia.
Wang LL; Han Y; Guo Z; Han SQ; Liu T
Regul Pept; 2013 Sep; 186():116-22. PubMed ID: 23994276
[TBL] [Abstract][Full Text] [Related]
6. Left Ventricle Function During Therapeutic Hypothermia with Beta
Bergan HA; Halvorsen PS; Espinoza A; Kerans V; Skulstad H; Fosse E; Bugge JF
Ther Hypothermia Temp Manag; 2018 Sep; 8(3):156-164. PubMed ID: 29394143
[TBL] [Abstract][Full Text] [Related]
7. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
8. Effects of esmolol on systemic hemodynamics and heart rate variability measured using the Analgesia/Nociception Index in resuscitated piglets with Pseudomonas aeruginosa septic shock.
Boselli E; Jacquet-Lagrèze M; Ayoub JY; Bouvet L; Dauwalder O; Mansour C; Margez T; Paquet C; Restagno D; Allaouchiche B; Bonnet-Garin JM; Junot S
J Vet Emerg Crit Care (San Antonio); 2018 Sep; 28(5):447-456. PubMed ID: 30074662
[TBL] [Abstract][Full Text] [Related]
9. Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension.
Garnock-Jones KP
Drugs; 2012 Jan; 72(1):109-32. PubMed ID: 22191799
[TBL] [Abstract][Full Text] [Related]
10. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction).
Pizarro G; Fernández-Friera L; Fuster V; Fernández-Jiménez R; García-Ruiz JM; García-Álvarez A; Mateos A; Barreiro MV; Escalera N; Rodriguez MD; de Miguel A; García-Lunar I; Parra-Fuertes JJ; Sánchez-González J; Pardillos L; Nieto B; Jiménez A; Abejón R; Bastante T; Martínez de Vega V; Cabrera JA; López-Melgar B; Guzman G; García-Prieto J; Mirelis JG; Zamorano JL; Albarrán A; Goicolea J; Escaned J; Pocock S; Iñiguez A; Fernández-Ortiz A; Sánchez-Brunete V; Macaya C; Ibanez B
J Am Coll Cardiol; 2014 Jun; 63(22):2356-62. PubMed ID: 24694530
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
Wang Z; Wu Q; Nie X; Guo J; Yang C
Clin Drug Investig; 2015 Nov; 35(11):707-16. PubMed ID: 26387030
[TBL] [Abstract][Full Text] [Related]
12. [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial].
Ibáñez B; Fuster V; Macaya C; Jiménez-Borreguero J; Iñiguez A; Fernández-Ortiz A; Sanz G; Sánchez-Brunete V
Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():28-33. PubMed ID: 21807284
[TBL] [Abstract][Full Text] [Related]
13. A randomised study of perioperative esmolol infusion for haemodynamic stability during major vascular surgery; rationale and design of DECREASE-XIII.
Bakker EJ; Ravensbergen NJ; Voute MT; Hoeks SE; Chonchol M; Klimek M; Poldermans D
Eur J Vasc Endovasc Surg; 2011 Sep; 42(3):317-23. PubMed ID: 21632265
[TBL] [Abstract][Full Text] [Related]
14. Effects of betaxolol on heart rate in patients with a recent transmural myocardial infarction.
Yang XS; Coupez R; Ector H; Kesteloot H; De Geest H
Acta Cardiol; 1987; 42(4):273-86. PubMed ID: 2889303
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of esmolol for heart rate control in patients with acute aortic dissection.
Krenz JR; O'Brien ME; Lee J; Hayes BD
Am J Emerg Med; 2021 Jun; 44():312-314. PubMed ID: 32354528
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of nicardipine and esmolol on the cardiac cycle, intracardiac hemodynamic and endothelial shear stress in patients with unstable angina pectoris and moderate coronary stenosis: results from single center, randomized study.
Chen SL; Hu ZY; Zhang JJ; Ye F; Kan J; Xu T; Liu ZZ; Zhang YJ; Zhang JX; Chen M
Cardiovasc Ther; 2012 Jun; 30(3):162-71. PubMed ID: 22099625
[TBL] [Abstract][Full Text] [Related]
17. The common Arg389gly ADRB1 polymorphism affects heart rate response to the ultra-short-acting β(1) adrenergic receptor antagonist esmolol in healthy individuals.
Muszkat M; Hoofien A; Orlanski-Meyer E; Makhoul H; Porat E; Davidson EM; Blotnick S; Caraco Y
Pharmacogenet Genomics; 2013 Jan; 23(1):25-8. PubMed ID: 23114278
[TBL] [Abstract][Full Text] [Related]
18. Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma.
Self T; Rogers ML; Mancell J; Soberman JE
Am J Med Sci; 2011 Jul; 342(1):56-61. PubMed ID: 21293248
[TBL] [Abstract][Full Text] [Related]
19. Effect of esmolol on oxidant status and antioxidant activity in acute myocardial infarction.
Daga MK; Chaudhary M; Sharma B; Bhattacharjee J; Ghambhir DS; Arora N; Sudha R
J Assoc Physicians India; 2003 Jul; 51():677-80. PubMed ID: 14621036
[TBL] [Abstract][Full Text] [Related]
20. Diltiazem versus esmolol for acute rate control in the emergency department.
Harvey S; Wilson K; Brad Hall A
Am J Emerg Med; 2017 Nov; 35(11):1760-1762. PubMed ID: 28465013
[No Abstract] [Full Text] [Related]
[Next] [New Search]
